Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease.
A
A
Pyrpasopoulou
V G
VG
Athyros
A
A
Karagiannis
F
F
Chrysomallis
C
C
Zamboulis
D000293:Adolescent; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009336:Necrosis; D017514:Pityriasis Lichenoides / Q000150:complications / Q000473:pathology / Q000628:therapy*; D011239:Prednisolone / Q000627:therapeutic use; D018805:Sepsis / Q000209:etiology
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D011239:Prednisolone; D008727:Methotrexate